Analysis of the clinical practice of the pharmacist in a community pharmacy: A Cross-sectional Study from Brazil

Main Article Content

Marcos Felipe Rodrigues de Souza https://orcid.org/0000-0002-6246-7525
Maria Pantoja Moreira de Sena https://orcid.org/0000-0001-6641-4618
Camila Martins Oliveira https://orcid.org/0000-0002-6425-2384
Clarisse Andrade Sales https://orcid.org/0000-0002-9451-666X
Renato Bruno Cavalcante de Melo https://orcid.org/0000-0002-6159-3802
Luann Wendel Pereira de Sena https://orcid.org/0000-0001-9363-5766

Keywords

Pharmaceutical care, Pharmaceutical services, Community pharmacies, Pharmaceutical.

Abstract

Background: The pharmaceutical profession has experienced renewals over time. In community pharmacies, pharmaceutical services contribute to the public health system in Brazil. The development of these tasks, in collaboration with professionals from the multidisciplinary team, demonstrates the involvement with the well-being, health and improvement of the patient’s life. Objectives: This study aimed to identify the professional practice of pharmacists, their understandings and attitudes towards clinical practice in community pharmacies in northern Brazil. Methods: This is a cross-sectional descriptive study, based on a questionnaire carried out with pharmacists for seven months in the municipality of Belém, in the state of Pará. Data were expressed using descriptive statistics and the results were shown as a percentage. Results: 182 pharmacists participated. Females were predominant (80.2%) and the average age of participants was 34.2 years. 77.4% graduated from private institutions and 59.3% already have a specialization. 38.4% hold the position of technical director. 50.5% of respondents say that community pharmacies have a reserved place for service. The most used clinical services were pharmacotherapy review (89.5%), health education (60.9%), dispensing (34%), therapeutic monitoring (25.8%) and pharmacotherapeutic follow-up (4.9%). In the study, it was realized that community pharmacies should not be seen as a commercial place but rather as a health care facility. Conclusions: Therefore, these establishments must adapt at a structural and professional level, to meet an increasingly growing demand of a population in need of services offered with quality health care.

Downloads

Download data is not yet available.
Abstract 110 | PDF Downloads 177

References

1. Melo DA, Castro LLC. Pharmacist’s contribution to the promotion of access and rational use of essential medicines in SUS.Ciênci Saúde Colet. 2017;22(1):235-44. https://doi.org/10.1590/1413-81232017221.16202015
2. Oliveira NVBV, Szabo I, Bastos LL, et al. The pharmacists’ professional practice in Brazil: sociodemograficamentephic profile anddynemics of work in Pharmacies and private drugstores. Saúde Soc. São Paulo. 2017;26(4):1105-21. https://doi,org/10.1590/S0104-12902017000002
3. Araújo PS, Costa EA, Junior AA, et al. Atividades farmacêuticas de natureza clínica na atenção básica no Brasil. Rev SaúdePública. 2017;51Supl2:6s. https://doi.org/10.11606/S1518-8787/2017051007109
4. Álvarez J, Alves MCGP, Escuder MML, et al. Pesquisa nacional sobre acesso, utilização e promoção do uso racional demedicamentos: métodos. Rev Saúde Publica. 2017;51Supl2:4s. https://doi.org/10.11606/S1518-8787/2017051007027
5. Souza LB, Souza DM, Souza SM, et al. Importância do farmacêutico clínico no uso seguro e racional de medicamentos noâmbito hospitalar. Rev Pensar Acadêmico. 2018;16(1):109-24. https://doi.org/10.21576/rpa.2018v16i1/360
6. Melo AC, Trindade GM, Freitas AR, et al. Community pharmacies and pharmacists in Brazil: A missed opportunity. Pharm Pract(Granada). 2021;19(2):2467. https://doi.org/10.18549/PharmPract.2021.2.2467
7. Conselho Federal de Farmácia. [Resolução nº 585 de 29 de Agosto de 2013: Regulates clinical assignments pharmacist and makes other arrangements]. https://www.cff.org.br/userfiles/file/resolucoes/585.pdf (accessed Nov 25, 2021).
8. Conselho Federal de Farmácia. [Resolução nº 586 de 29 de Agosto de 2013: Regulates pharmaceutical prescription and gives other provisions]. https://www.cff.org.br/userfiles/file/noticias/Resolu%C3%A7%C3%A3o586_13 (accessed Nov 25, 2021).
9. Souza AF, da Silva MR, dos Santos JB, et al. Medication adherence and persistence of psoriatic arthritis patients treated with biological therapy in a specialty pharmacy in Brazil: a prospective observational study. Pharm Pract (Granada). 2021;19(2):2312. https://doi.org/10.18549/PharmPract.2021;2:2312
10. Rossignoli P, Pontarolli D, Corrêa LG, et al. Innovating in clinical pharmacy services at the specialized component of pharmaceutical management in the state of Paraná. Rev Saude Públ Parana. 2019;2(1):125-39. https://doi.org/10.32811/25954482-2019v2n1p125
11. França C, Andrade LG. Performance of the Pharmacist in health care in community Pharmacies. Ann Phamacother. 2021;7(9):10-20. https://doi.org/10.51891/rease.v7i9.2223
12. Barberato LC, Scherer MDDA, Lacourt RMC. The pharmacist in the Brazilian Primary Health Care: insertion under construction. Cien Saude Colet. 2019;24(10):3717-3726. https://doi.org/10.1590/1413-812320182410.30772017
13. Conselho Federal de Farmácia. [Pharmaceutical services directly aimed at the patient, family and community contextualization and conceptual framework]. Brasília;CFF;2016. ISBN 978-85-89924-20-7.
14. Melo AC, Resende KA, Queiroz NS, et al. Is the reduction of codes of pharmaceutical procedures a concern of society? Rev Bras Farm Hosp Serv Saude. 2019;10(4):535. https://doi.org/10.30968/rbfhss.2019.104.0535
15. Sena LWP, Pantoja CSC, Souza DAS, et al. Prevalence of enteroparasitosis in a riverside community in the state of Pará, Brazil. Electronic J Collection Health. 2020;12(11):e4710. https://doi.org/10.25248/reas.e4710.2020
16. Melo AC, Galato D, Maniero HK, et al. Pharmacy in Brazil: Progress and Challenges on the Road to Expanding Clinical Practice. Inter Perspect on Pharma Pract. 2017;70(5):381-390. https://doi.org/10.4212/cjhp.v70i5.1700
17. Borges MC, Santos LP, Zago AM, et al. Socioeconomic development of cities and risk factors for non-communicable diseases: a comparative study across Brazilian state capitals. J Public Health (Oxf). 2016;38(4):653-359. https://doi.org/10.1093/pubmed/fdv202
18. Carvalho MN, Álvarez J, Costa KS, et al. Força de trabalho na assistência farmacêutica da atenção básica do SUS, Brasil. Rev Saúde Pública. 2017;51Supl2:16s. https://doi.org/10.11606/S1518-8787.2017051007110
19. Cazarim MS, Freitas O, Penaforte TR, et al. Impact Assessment of Pharmaceutical Care int the Management of Hypertension and Coronary Risk Factors after Discharge. PLoS ONE. 2016;11(6):e0155204. https://doi.org/10.1371/journal.pone.0155204
20. Gadelha CAG, Braga PSC, Montenegro KBM, et al. Acess to vaccines in Brazil and the global dynamics of the Health Economic Industrial Complex. Reports in Public Health. 2020;36:e00154519. https://doi.org/10.1590/0102-311X00154519.
21. Guimarães PHD, Pacheco RP, Morais YJ. Pharmaceutical care and the use of Over-the-Counter Medications (MIPs). Research, Society and Development. 2021;10(12):e485101220405. https://doi.org/10.33448/rsdv10i12.20405